Gene editing plus ultrasound eradicate aggressive liver cancer in mice
Cancer Liver cancer Hepatocellular Carcioma

Gene editing plus ultrasound eradicate aggressive liver cancer in mice

Dr. Abdulaziz Aldayel
Dr. Abdulaziz Aldayel

In 10 seconds? Scientists have used CRISPR/Cas9 gene-editing technology and nanoparticles to make cancer cells sensitive to a therapy that shrunk liver cancer in test animals.

What did they do? They’ve combined the gene-editing technology with a form of targeted radiation therapy knowns as Sonodynamic therapy to stop one of the most aggressive cancers worldwide, Hepatocellular carcinoma (that’s a fancy way of saying liver cancer). Sonodynamic therapy utilizes a low form of radiation in combination with drugs to release ‘reactive oxygen species’ (let’s call it ROS) at the tumor sites.

Get unlimited access to our 3-min Digests and other premium features

Choose your plan:

Personal

$99/year

✅ Includes 7-day free trial for new users
✅ Weekly Recap
✅ Daily newsletter
✅ Access 4 topic areas of your choosing
✅ Access all citations and resources
✅ Gain background knowledge with a Quick Dive
✅ The Sparrow Sessions Podcast
✅ No ads
❌ Direct access to the Expert Network
❌ Your questions - answered by an Expert Scientist
❌ 12 hours of consultations with our fabulous experts per year (that’s 1 hour per month!)
❌ Access to all topic areas as we scale the Content Library

We'll send you a reminder email 3 days before your trial ends.

Start my free trial

Professional

$3499/year

✅ Includes 7-day free trial for new users
✅ Weekly Recap
✅ Daily newsletter
✅ Access all citations and resources
✅ Gain background knowledge with a Quick Dive
✅ The Sparrow Sessions Podcast
✅ No ads
✅ Direct access to the Expert Network
✅ Your questions - answered by an Expert Scientist
✅ 12 hours of consultations with our fabulous experts per year (that’s 1 hour per month!)
✅ Access to all topic areas as we scale the Content Library

We'll send you a reminder email 3 days before your trial ends.

Start my free trial